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Introduction
Many treatments are available for Borderline Person-
ality Disorders (BPDs), but only a few studies are avail-
able for other personality disorders (PDs), in particularly
those characterised by social and emotional inhibition
(Arnevik et al., 2009; Bamelis et al., 2014; Gullestad et
al. 2012). The dearth of outcome studies for this popula-
tion is a problem as the cumulative prevalence of these
PDs and associate presentations are accompanied by com-
plex symptoms and social problems (Karterud, Øien &
Pedersen, 2011; Soeteman, Verheul & Busschbach, 2008).
Recently, interest in these PDs is increasing, with authors
consistently noting the need for specific treatments, which
differ from those treatments usually adopted for BPD
(Dixon-Gordon, Turner, & Chapman, 2011). In particular,
many note that these disorders are maintained by typical
maladaptive interpersonal schemas, albeit named differ-
ently according to therapeutic orientation (Bowlby, 1969;
Dimaggio, Montano, Popolo, & Salvatore, 2013; Young,
1990). Therefore improvements require individuals to first
be more flexible about their attributions regarding self and
others in order to increase functioning and reduce distress.
One such treatment is Metacognitive Interpersonal
Therapy (MIT). This was first developed for the whole
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ABSTRACT
Patients with personality disorders (PDs) other than borderline, with prominent features of social inhibition and over-regulation of
emotions, are in need of specialized treatments. Individuals present with poor metacognition, that is the capacity to understand mental
states and use psychological knowledge for the sake of purposeful problem solving; and are guided by maladaptive interpersonal
schemas. We developed a short-term group intervention, Metacognitive Interpersonal Therapy in Groups (MIT-G), incorporating psy-
choeducational and experiential elements, to help these individuals become more aware of their drives when interacting with others;
and to help them adopt more flexible behaviors via improvements in metacognition. We present results of an effectiveness study, eval-
uating whether we could replicate the initial positive results of our first pilot randomized controlled trial. Seventeen young adults out-
patients with personality disorders were included in the 16 session program. Effect sizes were calculated for change from baseline to
treatment end for the primary outcome, symptoms and functioning (Clinical Outcomes in Routine Evaluation Outcome Measure) and
then for one putative mechanism of change – metacognition. Emotional dysregulation and alexithymia were also assessed. Qualitative
evaluations of the acceptability and subjective impact of the treatment were also performed. MIT-G was acceptable to participants.
There were medium to large magnitude changes from pre- to post- treatment on wellbeing, emotion dysregulation, alexithymia and
metacognition. These gains were maintained at follow-up. There was evidence of clinically significant change on key variables. MIT-
G appears acceptable to patients, as evidenced by the absence of drop-out from treatment. In light of the positive outcomes of this study
and the expanding evidence base, MIT-G is a candidate for dissemination and investigations in larger trials as a possible effective in-
tervention for PDs characterized by tendencies to overcontrol.
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range of PDs, (Dimaggio et al., 2007), then manualized
with particular attention to the PDs introduced above, usu-
ally diagnosed as Avoidant, Dependent, Obsessive Com-
pulsive, or Paranoid PDs, or PDs with covert narcissism
and dependent and passive-aggressive traits. These PDs
are also been defined as internalizing (Harford et al.,
2013; Krueger, McGue, & Iacino, 2001) or with promi-
nent traits of detachment and negative affectivity (Amer-
ican Psychiatric Association, 2013). MIT has
demonstrated effectiveness in a single case series of pa-
tients with PD (Dimaggio et al., 2017) and results have
been replicated in a multiple-baseline single case series
(Gordon-King, Schweitzer & Dimaggio, 2017).
PDs can be understood as a pathology of social rela-
tionships, so if therapy is designed in order to make clients
accept a group-based approach, such a format may be
more ecologically valid and outcomes may be easier to
translate into real life. For this reason and to increase eco-
nomic viability (making the therapy more likely to be ap-
plied in public mental health settings) an adaptation,
Metacognitive Interpersonal Therapy in Group (MIT-G)
has been devised; (Popolo et al., 2018). MIT-G rests on a
series of assumptions, particularly: i) PDs feature poor
metacognition; and ii) humans are driven by a set of evo-
lutionarily shaped motives. Providing patients with infor-
mation about these motives helps them to quickly gain an
understanding of what drives them to act, and develop an
understanding of the cognitive and affective processes de-
veloping during interpersonal interactions. Patients also
better understand better how their maladaptive interper-
sonal schemas develop around these motives. As an ex-
ample – when driven by the social rank motive, a patient
may have a dominant self-image of themselves as flawed,
inferior and inept. Thus, they predict the other will criti-
cize him or her, and accordingly the patient perceives their
need to be appreciated has been frustrated.
Metacognition
We engage in metacognitive activity by identifying
and understanding how we feel and what drives us to act,
and by forming an integrated view of ourselves despite
the various mental states continuously alternating in our
minds. We identify the contents of experience on the basis
of perceptual and linguistic cues, as well as using chains
of inferences about mental functioning. For example, we
can identify our emotional state by focusing on our bodily
sensations. We also use metacognitive skills when trying
to understand how others feel and the intentions that are
likely guiding their behavior. For example, we can guess
others’ emotions by observing their facial expressions,
posture and prosody. Lastly, metacognition includes the
ability to use an understanding of mental states to manip-
ulate and regulate them, which is metacognitive mastery.
For instance, mastery may be evidenced by manipulating
conditions in which we calm down, concentrate, relax or
enjoy ourselves. Overall, metacognition refers to the com-
bination of skills which enable humans to: identify mental
states and ascribe them to themselves and others; think,
reflect and reason about their own mental states (self-re-
flectivity) and think, reflect and reason about other’s men-
tal states (understanding others’ minds); use the
knowledge and reflections of their own and others’ mental
states to make decisions, solve problems or psychological
and interpersonal conflicts, and master subjective suffer-
ing (mastery).
An individual’s metacognitive skills can fluctuate as
the quality of their relationships varies. In particular, in
PDs metacognition greatly depends on levels of emotional
arousal and on the quality of relationships (Fonagy,
Gergely, Jurist, & Target, 2002). For example, if a person
perceives relational threats and expects the other to attack,
abuse or dominate, he or she resorts to basic attributions,
and easily think that the other’s mind is inhabited by hos-
tile or malicious intentions (Liotti & Gilbert, 2011;
Lysaker et al., 2011). Consequently, he or she will not be
able to flexibly form ideas about what is passing though
the mind of the other. In contrast, when the person is calm
and relaxed, he or she will be more likely to read the mind
of the other in more nuanced, realistic and context-spe-
cific way. Metacognition has been found to be impaired
in the wide range of PD and associated to symptoms and
interpersonal difficulties (Lysaker et al., 2014; Maillard
et al., 2017; Moroni et al., 2016; Outcalt et al., 2016; Pel-
lecchia et al., 2018; Semerari et al., 2014) and appears as
growing during successful treatments (Carcione et al.,
2011; Dimaggio, Vanheule, Lysaker, Carcione, & Nicolò,
2009; Maillard et al., 2017; Popolo et al., 2018; Semerari
et al., 2005).
Interpersonal motives
When individuals with PD are driven by specific per-
sonal motivations, they experience intense emotions,
often negative, and correspondingly have difficulties
recognizing what they feel, leading to difficulties in un-
derstanding the intentions of others and regulating one’s
own behavior on the basis of awareness of mental states
(Liotti & Gilbert, 2011). In the realm of social relation-
ships humans are driven by goals they need to reach in
order to feel safe, find their place in the society, and live
a fully adapted and fulfilling life. In an evolutionary
framework, the relevant goals human pursue are: social
rank/competition, attachment, sexuality, group belong-
ing or group inclusion, caregiving, cooperation with
peers to reach shared goals and autonomous exploration
of the environment (which includes curiosity over psy-
chological states and processes) (Fassone et al., 2016;
Gilbert, 1989; 2005; Ivaldi, 2016; Lichtenberg, Lach-
mann, & Fosshage, 2016; Liotti & Gilbert, 2011;
Paanksepp, 1988).
Every motive has specific triggers and individuals ex-
perience a range of typical thoughts and affects depending
on their prediction of whether the motive is fulfilled or
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unfulfilled. As an example, social rank becomes active in
the presence of limited resources. In order to have access
to these resources individuals enter into competition in
order to establish priority of access. Typical emotions
linked to this are: rage when one’s own status is threat-
ened; or pride and superiority when we evaluate that we
have the status we want and think we deserve. Conversely
when individuals consider they are inferior, they fear so-
cial judgement, experiencing shame, embarrassment and
humiliation. Sadness is also relevant as an individual may
think they have lost the chance to have fast track access
to resources, and may predict that things will not change
in the future.
Development of metacognitive interpersonal therapy
in group
We hypothesized that metacognitive functioning could
be effectively trained in a group setting, creating a semi-
naturalistic space where patients can practice these abili-
ties by interacting with others in a protected area. In the
course of exchanges with others, participants try to iden-
tify the elements that distinguish their interpersonal pat-
terns, which are automatically activated and upon which
they do not usually reason in real life. The feedback that
they receive from the group enables them to evaluate their
convictions and their behaviors according to a different
perspective and not always in the usualway. The individ-
ual can then try to wonder about what others think and
find out they may have beliefs or viewpoints different
from those they anticipated. With these ideas, we devel-
oped MIT-G, with the goal of delivering an effective ther-
apy at reduced cost. 
MIT-G aims to improve metacognition so that partic-
ipants can use a richer and fine grained understanding of
mental states to regulate interpersonal interactions that de-
velop when they are driven by relevant personal motives.
For example, a young man desires to date a woman whom
he very much likes, but he is blocked by a sense of con-
fusion and agitation. He becomes unable to decode what
is passing through the mind of the woman: Does she like
him? Is she happy, upset, why is she blushing? In this state
of confusion the young man is likely to resort to maladap-
tive schema-driven attributions: “She is not interested in
me, I am disappointing her” (Dimaggio et al., 2013). MIT-
G proceeds from the basis that the understanding of men-
tal states can be taught and trained. Explaining the most
important human motives driving human behavior to par-
ticipants can help them to make sense of others’ actions.
Psychoeducation stimulates reflection in patients on their
relational skills and coping with daily difficulties. These
techniques come into play during the exercise of different
metacognitive skills in the interpersonal exchange. In
order to practice metacognitive skills we use role play as
a technique that allows patients to respond to interper-
sonal difficulties in a contained safe environment. This
helps stimulate a clearer understanding of their own men-
tal states and correspondingly enables them to be more
flexible and context-specific in ascribing mental states to
the other. First, patients write an autobiographical episode
concerning the motive presented during psychoeducation.
The patient then role-plays the episode, and after the en-
actment a group discussion ensues, focused on under-
standing the mental states of the actors.
MIT-G was reported to be effective in a pilot random-
ized clinical trial (Popolo et al., 2018). Ten outpatients
participated in MIT-G and pre-post outcomes were com-
pared with 10 patients who received TAU. Drop-out rate
was low (2 out of 10), and session attendance high
(92.19%). Participants in the MIT-G arm reported symp-
tomatic and functional improvement equivalent to large
effect sizes. Emotion dysregulation and alexithymia also
significantly improved. Outcomes for metacognition also
increased significantly from baseline to completion of
treatment, particularly in the domains of self-awareness,
decentration and mastery. Results were maintained at fol-
low-up.
Metacognitive interpersonal therapy in group
(MIT-G) structure
MIT-G comprises a short-term term manualized pro-
tocol, which includes psychoeducational and experiential
aspects. The number of participants can vary from 5 to 10
to encourage active participation of all in a spirit of be-
longing and cooperation, and to ensure a participant’s
presence sufficient to form the group. The treatment is
aimed at patients with PDs characterized by inhibited and
over-regulated aspects (Dimaggio et al., 2018). 
The MIT-G protocol consists of 16 weekly sessions
lasting 2 hours each, during which basic interpersonal
motives are described: i) agonistic, ii) affiliation/mem-
bership, iii) attachment, iv) tracking, v) exploratory, vi)
sexual and vii) cooperative. Two sessions are dedicated
to each system (three for the cooperative one, which ap-
pears the most difficult to grasp). The final session is de-
voted to reflections on patients’ experiences of the
program, changes achieved and identifying further is-
sues that they may wish to resolve in the future. Each
group session is divided into two: a first psychoeduca-
tional phase, during which the interpersonal motive cov-
ered in the session is described; and an experiential
phase involving a role play with subsequent discussion,
where a story written by a patient about the motive pre-
sented is staged. The conductors of group are two MIT-
certified therapists. 
Three individual sessions conducted by one of the
group’s facilitators are also arranged with each patient.
The first session is held before the start of the group, the
second in the course of the treatment and the third at the
end of the group. During the first individual session, the
therapist elicits narrative episodes related to the relational
problems reported by the patient. At the end of the ses-
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sion, he or she shares a structured summary of the events
following the typical structure of the interpersonal
schemas (Dimaggio et al., 2013), including a general rep-
resentation of it’s functioning in the individuals relation-
ships. The intermediate individual session is used to
explore and clarify the group’s progress from the perspec-
tive of the individual. It is then possible to evaluate ele-
ments of individual functioning or interpersonal
difficulties that may impact upon the patient’s participa-
tion in the group sessions. This reduces the chance of
early interruptions in treatment and stimulates more active
participation in the group itself. During the intermediate
individual session, it is also possible to analyse any dys-
functional relational strategies that the patient has put in
place during the group, locating these in relation to the
possible activation of reconstructed schema. The last in-
dividual session aims to give the patient space to share his
or her experience, deepening the understanding of what
he or she has learnt about how to deal with interpersonal
situations. Therapist and patient also devise a plan for how
to promote further progress.
Structure of sessions: psychoeducation
Every session includes psychoeducation followed by
experiential work. Psychoeducational elements are pre-
ceded by a warm up, during which participants can freely
discuss general topics. For each motive, the conductors
illustrate what it is, the conditions that activate and deac-
tivate the motive, how relationships take place in this case,
and the emotions that are activated with each motive.
Thereafter, each motive is illustrated in two consecutive
sessions, for about 10 minutes apiece. The conductors pay
attention to the non-verbal communication amongst the
participants, in order to be able to adapt their exposure to
the group’s requests/functioning, in order to foster a
greater involvement. 
After displaying the theoretical contents, the conduc-
tors present audio-video material, such as films, cartoons,
clips, to illustrate the typical scenarios related to that mo-
tive. The aim is to facilitate rapid assimilation of the topics
described through visual material. This material has the
advantage of readily capturing the attention of partici-
pants, and serves to simplify the concepts described, using
memorable, easily accessible scenes. 
At the end of the video, which lasts about ten minutes,
participants freely express their ideas on the topics cov-
ered. The purpose is to consolidate the knowledge of the
motivation discussed and to clarify any doubts brought by
the group. The video stimulates participants to identify
processes involving the protagonists of the scenes ob-
served, and primes the emergence of autobiographical
memories. Each patient can express ideas about the video
as well as on the material illustrated in the theoretical part,
recalling personal associated relational experiences. The
conductors try to summarise this material, linking to the
theoretical arguments related to the motive. 
Structure of sessions: experiential phase 
After a short pause, the conductors ask the participants
to write a short autobiographical episode involving pro-
tagonists in the interaction with one or more people;
specifically, a scene in which they believe the motive de-
scribed in the psychoeducational phase has been activated.
The explicit purpose is to obtain a script to for the role
play, first denoting the spatial (where) and temporal
(when) boundaries in which the episode takes place. Par-
ticipants then identify the characters present in the scene
(age, sex, work, type of relationship that binds them to the
author) and the sequence of actions succeeded. Among
the written episodes, the therapists choose the one most
relevant to motivation addressed and/or the motive iden-
tified by the participant as the most distressing element.
The purpose of role play is to transmit and encourage
the acquisition of content from experience. The first role
play of a specific motive focuses on the activation of self-
reflective capacity. In the second session of the motive,
the focus is on the promotion of a better understanding of
others’ minds and the elaboration of new, more effective
strategies to manage interpersonal problems. The same
scene is represented twice. In the first, the author repre-
sents himself and the episode described is reproduced
more or less faithfully. In the second role play, instead,
the roles are reversed and the patient now plays the role
of the protagonist giving them the opportunity to add
something personal to the script. The reversal of roles di-
rectly stimulates the theory of the mind and decentration
skills of the actors, strengthening their awareness of their
own internal states. During role play the participants are
not forced to fully respect the written script. In the first
session of each motive, the role play ends where the orig-
inal episode ended. In the second session, instead, after
the first enactment, the protagonist is asked to rescript the
scene, introducing new attempts to solve the difficulties
that emerged during the episode.
When role play is finished the conductors introduce
the discussion, in which all the participants confront them-
selves on the experiences lived and the reflections made
during the course and after the role play. In this phase, the
conductors ask more specific questions to solicit the
metacognitive functions: the aim being to get the individ-
ual to solicit these functions repeatedly in different ses-
sions. The conductors propose simple questions to the
group, and only in some cases to the single participant,
thus guiding reflection a training the specific function for
that session. The discussion does not follow a rigid se-
quence, allowing each individual to elaborate their own
reflections according to their own times, and to feel free
to express their own content as well as to comment upon
others’ content. 
In the first session of each motive the conductors ask
the participants to focus on theemotions they have expe-
rienced during enacting or watching the role play. After
asking the participants to describe the emotional and cog-
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nitive components of their own internal states, the con-
ductors help the group reflect on the subjective nature of
their ideas, considering the possibility that these do not
necessarily reflect what has happened, but that they can
have different positions and perspectives. At this phase,
we also investigate the strength of the conviction of the
ideas reported by the participants in relation to the ob-
served scene.
In the role play of the second session of each motive,
the discussion is focused on specific relational strategies
used by the actors during the representation. In the first
part of the discussion, the aim is to stimulate the under-
standing of others’ minds in participants, starting from the
evaluation of motivations underlying the actors adoption
of the relational modalities observed. During the discus-
sion, the emergence of different opinions permits partici-
pants to enrich their repertoire of interpretations of others’
behavior. At this stage there is also exploration of the dif-
ferences between their style of response and that of the
character, again emphasizing how different interpretations
can be possible. In the second part of discussion, mastery
skills are stimulated. First, conductors ask the main actor
to describe his or her experience and to say whether
he/she found the solution useful, and how difficult it was
to adopt it. The conductors then ask observers whether
they consider the new behavioural modalities staged by
the actors to be effective, starting from the reactions they
have elicited in the other characters in role play. Concur-
rently, the conductor offers feedback on more adaptive
strategies, and highlight where strategies may be ineffec-
tual or detrimental in everyday life. 
Study aims and hypotheses
In this study, we wanted to further test the acceptabil-
ity of MIT-G and its capacity to increase functioning and
reduce distress. We also wanted to test the ecological va-
lidity of the approach in an implementation setting. MIT-
G groups were run in real-life conditions in a public
mental health outpatient unit. We aimed to assess the mag-
nitude of pre-post change on symptoms and functioning
after receipt of MIT-G. In addition, we predicted a growth
in metacognitive capacities as a potential mechanism of
change.
Design 
Young adults, aged between 16 and 25, and seeking
treatment in Outpatient Mental Health Service in Modena,
Italy, were screened for inclusion. Patients were referred
by their treating clinicians, psychologists and psychiatrists
working in this service between December 2016 and Jan-
uary 2017 on the basis of the presence of the following
PDs: Avoidant, Dependent, Obsessive-Compulsive, Nar-
cissistic, Paranoid, Passive-Aggressive and Depressive
disorder, or PDNOS (meeting at least 10 SCID-II criteria).
Exclusion criteria were: intellectual disability, organic
brain disease or severe somatic disease impairing neuro-
logical function, psychosis, bipolar I disorder or substance
abuse severe enough to require specialized treatment. Pa-
tients hospitalized in the month before the beginning of
recruitment were excluded, as were patients with promi-
nent emotional dysregulation, intense suicidality or phys-
ical aggression towards others (due to overlap with
Borderline PD). Substance abuse or drug intoxication
were also exclusion criteria.
Materials
Symptoms and functioning were evaluated using the
Clinical Outcomes in Routine Evaluation Outcome Meas-
ure (CORE-OM) (Evans et al., 2002), a 34-item self-re-
port questionnaire. CORE-OM assesses problems and
symptoms in four domains: subjective wellbeing, symp-
toms (anxiety, depression, somatic complaints, trauma-re-
lated); general, relational and social functioning, and risk
(aggression towards self, e.g. suicidality, or towards oth-
ers, e.g. aggression). Reliability for total score ranged
from α=.91 pre-treatment to α=.97 at follow-up. Subscale
reliability was high at all timepoints, with the exception
of pre-treatment wellbeing α=.44 and risk α=.63.
Metacognition was assessed with the Metacognition
Assessment Scale-Abbreviated (MAS-A) (Lysaker et al.,
2005) a rating scale adapted from the MAS (Semerari et
al., 2003). Scores are assigned after reading transcripts
from the Indiana Interview for Psychiatric Illness
(Lysaker et al., 2002). MAS-A evaluates 4 domains of
metacognition: Self-reflectivity, Awareness of the Mind
of the Other, Decentration and Mastery. 
Emotional dysregulation was assessed with the Diffi-
culties in Emotion regulation scales (DERS) (Gratz &
Roemer, 2004; Giromini et al., 2012), a self-report ques-
tionnaire. Here, we used the total score only. Reliability
for total score ranged from α=.92 pre-treatment to α=.80
at follow-up.
Alexithymia was assessed with the Toronto Alex-
ithymia Scale-20 (TAS-20) (Bagby et al., 1994 a; 1994b),
a 20-item self-report measure. TAS-20 has 3 subscales:
Difficulty Describing Feelings subscale, Difficulty Iden-
tifying Feeling subscale and Externally-Oriented Think-
ing subscale. Reliability for total score ranged from α=.86
pre-treatment to α=.91 at follow-up. Subscale reliability
was acceptable at all timepoints (α.73-.88).
Procedures
Seventeen patients met inclusion criteria and were re-
ferred to 2 MIT-G groups (7 and 10 participants respec-
tively). While undergoing MIT-G all patients continued
TAU, which consisted of psychiatric medication monitor-
ing (as required), supportive counselling and rehabilitation.
The conductors, different in the two groups, carried out a
specific training on MIT-G performed in their unit. During
program delivery, therapists were supervised by one of the
two developers of MIT-G (RP) for 1.5 hours per fortnight.
Assessments of symptoms, functioning and psychological
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processes were conducted at baseline and repeated for both
groups at termination and at a 3-months follow-up. Psy-
chologists performing assessments were independent of
group facilitators and therapists were blinded to outcome
and process measures until after follow-up. 
Statistical analyses
Descriptive statistics were calculated to examine demo-
graphic and clinical characteristics. Shapiro- Wilk’s test
was used to assess normality of the distributions of the pre-
treatment measures. Results indicated that the CORE-OM’s
Risk dimension (P<.05), and MAS’s Self-Reflectivity
(P<.001) and Mastery (P<.05) dimensions were signifi-
cantly different from the normal distribution. Paired sample
t-tests were calculated to examine whether individuals dis-
played significant improvements as measured by the out-
come variables. All tests were two-tailed, with an alpha
level of 0.05. Bootstrapped confidence intervals for mean
change were created using 1000 resamples. Effect size was
estimated using Cohen’s d where effect sizes of 0.2 are con-
sidered small, 0.5-0.6 medium, and ≥0.80 large. Data analy-
ses were carried out using SPSS for Windows, Version
24.0. To estimate clinically relevant changes across treat-
ment, reliable change indices were calculated using the
Leeds Reliable Change index calculator (Morley &
Dowzer, 2014). Appropriate reference groups were used to
generate reliability data for CORE-OM (Evans et al., 2002),
and DERS (Giromini et al., 2012).
Results
We recruited 17 participants who met inclusion crite-
ria with an average age of 19 years (range=16-23). The
sample was predominantly female (83%) and the majority
of participants were students (n=15), with one unem-
ployed individual and one in employment. The first group
consisted of seven patients; six concluded treatment and
one dropped-out at the tenth session, having exceeded the
maximum number of absences indicated in the treatment
protocol (three non-attendances). Of the 6 completers, at-
tendance was very good, participants completed on aver-
age >14 of the 16 scheduled sessions (Attendance
rate=88.54%). The second group consisted of ten patients;
of these, nine ended the treatment and 1 dropped-out at
the fourth session. The patient who interrupted treatment
early, lived in the province, and had difficulty in reaching
the service regularly, without being be accompanied by
his/her parents. Of the 9 completers, attendance was very
good, with participants completing on average >14 of the
16 scheduled sessions (Attendance rate=90.28%).
Outcomes and changes as a function of treatment are
displayed in Table 1. From pre-post treatment participants
improved in terms of CORE Wellbeing, equivalent to a
large effect size (mean difference=10.9, 95% CI=4.82 to
15.71; P=.009; d=.91). Participants also improved on
DERS total, equivalent to a large effect size (mean differ-
ence=17, 95% CI=3.84 to 28.41; P=.034; d=.74), as well
as on the Impulse Control Difficulty (mean differ-
ence=3.75, 95% CI=1.25 to 6.25; P=.017; d=.82) and Lack
of Emotional Awareness (mean difference=3, 95% CI=.83
to 4.92; P=.022; d=.85) subscales. Participants’ total score
on TAS (mean difference=9.43, 95% CI=3.79 to 15.43;
P=.004; d=.82) significantly reduced between baseline and
post-treatment, and also on the Difficulty Describing Feel-
ings (mean difference=3.64, 95% CI=1.14 to 8.21; P=.021;
d=.72) and Difficulty Identifying Feelings (mean differ-
ence=4.1, 95% CI=1.14 to 7; P=.022; d=0.7) subscales.
Between baseline and follow-up, paired samples t-
tests indicated that CORE-OM Total scores (without Risk
items) showed significant improvement equivalent to a
medium effect size (mean difference=5.030 95% CI=.98
to 8.96; P=.044; d=.66); and the Wellbeing subscale also
improved with a large magnitude effect (mean differ-
ence=7.08, 0 95% CI=2.92 to 11.25; P=.009; d=.93).
For emotion regulation, DERS total score showed a
large magnitude reduction (mean difference=19.27, 95%
CI=4.55 to 30.81; P=.02; d=.88); mirrored by large reduc-
tions in the Lack of Emotional Awareness and Lack of
Emotional Clarity subscales (respectively, mean differ-
ence=4.54, 95% CI=2.54 to 6.82; P=.022; d=1.17; and
mean difference=4.64, 95% CI=1.27 to 7.91; P=.036;
d=0.8). For alexithymia, there was a very large magnitude
reduction in TAS total score (mean difference=8.17, 95%
CI=5.67 to 10.42; P=.001; d=1.93); and large reductions in
the Difficulty Describing Feelings (mean difference=1.83,
95% CI=.58 to 3.08; P=.029; d=.81) and Difficulty Identi-
fying Feelings subscales (mean difference=4.25, 95% CI=2
to 6.33; P=.003; d=1.08). There were no significant differ-
ences between post-treatment and follow up measures, in-
dicating no decrease in gains made during treatment.
With regard to potential mechanisms of change, par-
ticipants’ metacognitive skills improved in all MAS-A
subscales, with large effect size. In particular, there were
significant differences between baseline and post-treat-
ment values for Self-Reflectivity (mean difference=-.87,
95% CI=-1.2 to -.57; P=.001; d=1.35), Awareness of the
Mind of the Other (mean difference=-.5, 95% CI=-.8 to -
.23,; P=.017; d=.88), Decentration (mean difference=-.53,
95% CI=-.9 to -.17; P=.03; d=.71), and Mastery (mean
difference=-.83, 95% CI=-1.26 to -.4; P=.015; d=.97).
Finally, outcome variables were further analysed using
the Reliable Clinical Index and Clinically Significant
Change (CSC) methods. For CORE-OM Wellbeing, be-
tween baseline and post-treatment outcomes, 6 partici-
pants showed reliable change, 5 of whom met the criterion
for clinically significant change (n=14). Analyses of
DERS total score revealed clinically significant change
for 1 participant and 6 participants showed reliable change
(n=12). In terms of subscales, for the DERS’ Impulse
Control Difficulties subscale, no participants showed
CSC, while 3 showed reliable change (n=15). Out of 15
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participants, 3 showed reliable change on DERS’s Lack
of Emotional Awareness subscale, among whom 1 partic-
ipant met the CSC criterion.
Discussion
Patients with over-controlled, socially and emotionally
inhibited patients require cost-effective specialized treat-
ments. MIT-G is a candidate treatment based on promising
results from a pilot randomized controlled trial (RCT)
(Popolo et al., 2018). In this feasibility study, we aimed at
replicating the results of the former trial in ecologically
valid conditions, in this case implemented as routine clin-
ical practice via an outpatient public service. In line with
expectations, patients adherence to therapy was high, with
15 out of 17 patient completing treatment. Importantly, re-
sults from the first trial (Popolo et al., 2018) were success-
fully replicated. Primary outcomes were symptoms and
functioning, which improved with medium to large effect
sizes. The secondary outcomes were emotion unawareness
and dysregulation, which also improved with medium to
large effects, which were particularly striking for alex-
ithymia. As regards metacognition as the hypothesized
mechanism of change (Semerari et al., 2003), improvent
was evident. In summary, patients in this sample had better
functioning and less symptoms post treatment, which was
accompanied by an increased capacity to understand men-
tal states and to use mentalistic knowledge for the sake of
purposeful regulation of both emotions and social interac-
tions. Importantly, gains were retained at follow-up.
Results encourage further testing of MIT-G in larger
samples under methodologically robust RCT conditions.
Equally, the results also support the potential for roll-out
of MIT-G as a treatment for avoidant and emotionally in-
hibited PDs in routine clinical settings, potentially accom-
panied by implementation science-derived routine
outcome evaluation.
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Table 1. Changes in symptoms and functioning across timepoints.
                                                               Baseline                Post-treatment              Follow-up           Effect size baseline  Effect size follow-up
Measure                                               Mean (SD)                 Mean (SD)                 Mean (SD)                         d                                 d
CORE-OM Total                                  17.66 (5.44)                12.98 (8.17)                13.72 (8.38)                      0.46                             0.59
Wellbeing                                             25.89 (5.33)               15.89 (9.43)a                        18.54 (8.21)b                                    0.91                             0.93
Problems                                              21.13 (7.92)                15.89 (8.45)                15.97 (10.1)                      0.41                             0.61
Functioning                                          18.03 (6.22)                12.97 (9.46)                13.75 (8.52)                      0.52                             0.63
Risk                                                       4.52 (4.82)                  5.23 (9.51)                     5 (8.4)                           0.07                             0.14
Total without Risk                               20.48 (5.98)                14.64 (8.27)               15.59 (8.88)b                                    0.56                             0.66
DERS Total                                          107.6 (24.1)               90.66 (23.6)a                        88.1 (13.44)b                                    0.74                             0.88
NonAccept                                           16.08 (6.69)                 12.5 (4.58)                 13.54 (4.45)                      0.53                              0.5
Goals                                                     17.5 (4.52)                  16.5 (4.23)                 16.36 (4.17)                      0.25                             0.41
Impulse                                                17.08 (5.74)               13.33 (3.79)a                           14.81 (3.6)                       0.82                             0.27
Aware                                                    17.5 (4.31)                 14.5 (4.85)a                            12.81 (4.6)b                                      0.85                             1.17
Strategies                                              23.83 (7.1)                 20.91 (7.47)                19.27 (3.97)                       0.4                              0.63
Clarity                                                  15.66 (5.22)                12.91 (4.77)               11.27 (2.79)b                                    0.44                              0.8
MAS                                                                                                                                                                                                            
Self-Reflectivity                                     4.2 (1.3)                   5.06 (1.08)a                                          -                               1.35                               -
Others                                                    3.4 (1.02)                   3.9 (0.78)a                                            -                               0.88                               -
Decentration                                         1.66 (0.89)                  1.7 (0.72)a                                            -                               0.71                               -
Mastery                                                 3.33 (1.12)                  4.16 (1.2)a                                            -                               0.97                               -
TAS Total                                             55.78 (12.7)               46.35 (14.7)a                        47.5 (14.96)b                                    0.82                             1.93
Describing Feelings                             16.42 (4.36)               12.78 (5.29)a                        14.25 (4.99)b                                    0.72                             0.81
Identifying Feelings                             19.64 (5.34)               15.57 (5.34)a                             16 (6.57)b                                          0.7                              1.08
Thinking                                              19.71 (5.73)                18.28 (5.84)                17.25 (5.61)                      0.45                             0.52
CORE-OM, Clinical Outcomes in Routine Evaluation Outcome Measure; DERS, Difficulties in Emotion regulation scales; MAS, Metacognition Assessment Scale; TAS, Toronto Alexithymia
Scale. aSignificant difference of P<.05 between baseline and post-treatment; bSignificant difference of P<.05 between baseline and follow-up.
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Limitations
There were a number of limitations to our study. First,
given that both the current sample and the earlier RCT
(Popolo et al., 2018) were comprised of young adults, re-
sults cannot be generalized to other age groups, in partic-
ular older patients. Another limitation was the absence of
a control group, which limits our scope to establish
whether change was caused by this specific program or
was simply due to being included in a structured therapy
program. Interpersonal functioning, which is the core fea-
ture of PD was not assessed. The relatively short duration
of follow-up also leaves us unable to comment on whether
results are sustained over time. 
Finally, we did not assess changes in employment and
work functioning, although we acknowledge these are key
aspects of social adaptation in young adults.
Conclusions
Patients with PDs characterized by prominent features
of social inhibition require specialized treatment. There
is also a pressing need to deliver treatments with sustain-
able costs ad with ecological validity, with the hope that
patients can generalize therapeutic gains to the ‘real
world’. MIT-G was developed with these goals, and in the
current study we showed that it can be successfully ap-
plied as part of routine treatment delivery in a public men-
tal health service. Acceptability was high with as evident
from the low number of drop-outs (2 out of 17), and there
was evidence of broad positive good outcomes in symp-
toms and functioning. Furthermore, participants emotion
awareness and regulation improved over treatment, as
well as their capacity to be aware of mental states and use
psychological knowledge for the sake of purposeful prob-
lem solving. With replication and using methodologically
rigorous clinical trials, MIT-G may be a promising effec-
tive and well accepted option for patients with PD. 
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Milan, Italy: Raffaello Cortina.
Gilbert, P. (1989). Human nature and suffering. London/New
York: Psychology Press/Guilford Press.
Gilbert, P. (2005). Compassion and cruelty: a biopsychosocial
approach. In Gilbert, P., Ed. Compassion: conceptualisa-
tions, research and use in psychotherapy (pp. 9-74). London,
UK: Routledge.
Giromini, L., Velotti, P., de Campora, G., Bonalume, L., & Za-
vattini G., C. (2012). Cultural adaptation of the difficulties
in emotion regulation scale: reliability and validity of an Ital-
ian version. Journal of Clinical Psychology, 68(9), 989-
1007. doi:10.1002/jclp.21876
Gordon-King, K., Schweitzer, R. D., & Dimaggio, G. (2017).
[page 162]                  [Research in Psychotherapy: Psychopathology, Process and Outcome 2018; 21:338]
Article
No
n-c
om
me
rci
al 
u
e o
nly
Behavioural activation in the treatment of metacognitive
dysfunctions in inhibited-type personality disorders: a case
study. Psychotherapy, 54, 252-259. doi:10.1037/pst0000120
Gratz, K. L., & Roemer, L. (2004). Multidimensional assess-
ment of emotion regulation and dysregulation: development,
factor structure, and initial validation of the difficulties in
emotion regulation scale. Journal of Psychopathology & Be-
havioral Assessment, 26, 1, 41-54. 
Gullestad, F. S., Wilberg, T., Klungsøyr, O., Johansen, M. S.,
Urnes, O., & Karterud, S. (2012). Is treatment in a day hos-
pital step-down program superior to outpatient individual
psychotherapy for patients with personality disorders? 36
months follow-up of a randomized clinical trial comparing
different treatment modalities. Psychotherapy Research,
22(4), 426-441. doi:10.1080/10503307.2012.662608
Harford, T. C., Chen, C. M., Saha, T. D., Smith, S. M., Ruan, W.
J., & Grant, B. F. (2013). DSM-IV personality disorders and
associations with externalizing and internalizing disorders:
Results from the National Epidemiologic Survey on Alcohol
and Related Conditions. Journal of Psychiatric Research,
47, 11, 1708-1716.
Ivaldi, A. (2016). Treating dissociative and personality disor-
ders: a motivational systems approach to theory and treat-
ment. London: Routledge.
Karterud, S., Øien, M., & Pedersen, G. (2011). Validity aspects
of the diagnostic and statistical manual of mental disorders,
fourth edition, narcissistic personality disorder construct.
Comprehensive Psychiatry, 52(5), 517-526. doi:10.1016/j.
comppsych.2010.11.001
Krueger, R.F., McGue, M., & Iacono, W.G. (2001). The higher-
order structure of common DSM mental disorders: internal-
ization, externalization, and their connections to personality.
Personality and Individual Differences, 30(7), 1245-1259.
Lichtenberg, J. D., Lachmann, F. M., & Fosshage, J. L. (2016).
Self and motivational systems: towards a theory of psycho-
analytic technique. New York: Routledge.
Liotti, G. & Gilbert, P. (2011). Mentalizing, motivation, and social
mentalities: theoretical considerations and implications for
psychotherapy. Psychology and Psychotherapy: Theory, Re-
search and Practice, 84, 9-25. doi:10.1348/
147608310X520094
Lysaker, P. H., Carcione, A., Dimaggio, G., Johannesen, J. K.,
Nicolò, G., Procacci, M., & Semerari, A. (2005). Metacog-
nition amidst narratives of self and illness in schizophrenia:
Associations with insight, neurocognition, symptom and
function. Acta Psychiatrica Scandinavica, 112, 64-71.
doi:10.1111/j.1600-0447.2005.00514.x
Lysaker, P. H., Clements, C. A., Plascak-Hallberg, C. D., Knip-
scheer, S. J., & Wright, D. E. (2002). Insight and personal nar-
ratives of illness in schizophrenia. Psychiatry, 65,197-206. 
Lysaker, P.H., Gumley, A., Brune, M., Vanheule, S., Buck, K.D.,
& Dimaggio, G. (2011). Deficits in the ability to recognize
one’s own affects and those of others: associations with neu-
rocognition, symptoms and sexual trauma among persons
with schizophrenia. Consciousness & Cognition, 20, 1183-
1192. doi:10.1016/j.concog.2010.12.018
Lysaker, P.H., Olesek, K., Buck, K., Leonhardt, B., Vohs, J.,
Dimaggio, G., Popolo, R. & Outcalt, J. (2014). Metacogni-
tive mastery moderates the relationship of alexithymia with
cluster C personality disorder traits in adults with substance
use disorders. Addictive Behaviors, 39, 558-561.
doi:10.1016/ j.addbeh.2013.11.007 
Maillard, P., Dimaggio, G., de Roten, Y., Despland, J-N., &
Kramer, U. (2017). Metacognitive processes and symptom
change in a short-term treatment for borderline personality
disorder: a pilot study. Journal of Psychotherapy Integra-
tion, 27(4), 445-459. doi:10.1037/int0000090
Morley, S. & Dowzer, C.N. (2014). Manual for the Leeds Reli-
able Change Indicator: Simple Excel(tm) applications for
the analysis of individual patient and group data. Leeds, UK:
University of Leeds.
Moroni, F., Procacci, M., Pellecchia, G., Semerari, A., Nicolò,
G., Carcione, A., Pedone, R., & Colle, L. (2016). Mindread-
ing dysfunction in avoidant personality disorder compared
with other personality disorders. Journal of Nervous and
Mental Diseases, 204(10), 752-757.
Outcalt, J., Dimaggio, G., Popolo, R., Olesek, K. L., Buck, K.,
& Lysaker, P. H. (2016). Metacognition moderates the rela-
tionship of disturbances in attachment with severity of bor-
derline personality disorder among individuals in treatment
for substance use disorders. Comprehensive Psychiatry, 64,
22-28. doi:10.1016/j.comppsych.2015.10.002 
Panksepp, J. (1998). Affective neuroscience: the foundations of
human and animal emotions. Oxford: Oxford University
Press.
Pellecchia, G., Moroni, F., Colle, L., Semerari, A., Carcione, A.,
Fera, T., … & Procacci, M. (2018). Avoidant personality dis-
order and social phobia: Does mindread- ing make the dif-
ference? Comprehensive Psychiatry, 80, 163-169.
doi:10.1016/j.comppsych.2017.09.011
Popolo, R., MacBeth, A., Canfora, F., Rebecchi, D., Toselli, C.,
Salvatore, G., & Dimaggio, G. (2018). Metacognitive inter-
personal therapy in group (MIT-G) for young adults person-
ality disorders. A pilot randomized controlled trial.
Psychology and Psychotherapy: Theory, Research & Prac-
tice. [Epub Ahead of print] doi:10.1111/papt.12182
Semerari, A., Carcione, A., Dimaggio, G., Falcone, M., Nicolò,
G., Procacci, M., & Alleva, G. (2003). How to evaluate
metacognitive functioning in psychotherapy? the metacog-
nition assessment scale and its applications. Clinical Psy-
chology and Psychotherapy, 10, 238-261. doi: 10.1002/
cpp.362
Semerari, A., Colle, L., Pellecchia, G., Buccione, I., Carcione,
A., Dimaggio, G., … & Pedone, R. (2014). Metacognition:
severity and styles in Personality Disorders. Journal of Per-
sonality Disorders, 28, 751-766.
Semerari, A., Dimaggio, G., Nicolò, G., Pedone, R., Procacci,
M., & Carcione, A. (2005). Metarepresentative functions in
borderline personality disorders. Journal of Personality Dis-
orders, 19, 690-710.
Soeteman, D. I., Verheul, R., & Busschbach, J. J. (2008). The
burden of disease in personality disorders: diagnosis-specific
quality of life. Journal of Personality Disorders, 22(3), 259-
268. doi:10.1521/pedi.2008.22.3.259
Young, J. E. (1990). Cognitive therapy for personality disorders:
A schema-focused approach. Sarasota, FL: Professional Re-
source Exchange, Inc.
                                              [Research in Psychotherapy: Psychopathology, Process and Outcome 2018; 21:338] [page 163]
Metacognitive interpersonal therapy in group
No
n-c
o
me
rci
al 
us
e o
nly
